HomeFBLG • NASDAQ
add
Fibrobiologics Inc
Previous close
$0.33
Day range
$0.34 - $0.40
Year range
$0.32 - $3.89
Market cap
18.88M USD
Avg Volume
1.17M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.04M | 50.30% |
Net income | -5.78M | -1,055.60% |
Net profit margin | — | — |
Earnings per share | -0.13 | — |
EBITDA | -4.97M | -50.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.87M | -37.82% |
Total assets | 8.74M | -16.48% |
Total liabilities | 8.62M | 11.47% |
Total equity | 125.00K | — |
Shares outstanding | 51.46M | — |
Price to book | ∞ | — |
Return on assets | -111.21% | — |
Return on capital | -133.46% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.78M | -1,055.60% |
Cash from operations | -3.97M | -52.42% |
Cash from investing | -6.00K | 45.45% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -3.98M | -314.56% |
Free cash flow | -2.73M | 39.66% |
About
Founded
2021
Headquarters
Website
Employees
13
